An exploratory phase II study of Eribulin re-challenge after short term therapy of 5-fuluorouracil for HER2-negative, advanced or recurrent breast cancer

An exploratory phase II study of Eribulin re-challenge after short term therapy of 5-fuluorouracil for HER2-negative, advanced or recurrent breast cancer

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) Vol. 138; p. S62
Main Authors: Takashima, T., Nishimura, S., Kawajiri, H., Mizuyama, Y., Nishimori, T., Yamagata, S., Tokunaga, S., Tezuka, K., Tei, S., Sunami, T., Ikeda, K., Ogawa, Y., Kashiwagi, S., Noda, S., Onoda, N., Ishikawa, T., Kudoh, S., Takada, M., Hirakawa, K., Ohira, M.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-10-2020
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(20)30693-6